- Methotrexate for Rheumatoid Arthritis
- What are Biologic Response Modifiers?
- Are Some Patients Unsuitable Candidates for Biologic Drugs?
- Why is Early, Aggressive Treatment Recommended?
A database from the Consortium of Rheumatology Researchers of North America was used to compare treatment plans of patients with elderly-onset rheumatoid arthritis (disease onset after age 60 years) and younger-onset rheumatoid arthritis (disease onset between 40 and 60 years). Study results, which were reported in the Annals of the Rheumatic Diseases (2006;65:1226-1229), indicated that elderly-onset rheumatoid arthritis patients received combination DMARDs (disease-modifying anti-rheumatic drugs) and biologic treatments less frequently than younger-onset patients even though both groups had identical disease duration as well as comparable disease severity and disease activity.
More Related Resources:
- Guide to Rheumatoid Arthritis
- Rheumatoid Arthritis Screening Quiz
- Test Your Knowledge: Rheumatoid Arthritis
- Rheumatoid Arthritis 101: Free E-Course Newsletter
- TNF Blockers for Rheumatoid Arthritis - Infection Risk Assessed in Older Patients
Photo by Stan Rohrer (iStockphoto)